[Venous thromboembolism and immobilization for medical reason].
Venous thromboembolism (VTE) is a common, severe and preventable disease. The severity of this entity ranges from isolated symptoms of deep vein thrombosis with favorable resolution to severe pulmonary embolism, with a high mortality rate. Several observational studies have reported the risk factors associated with VTE, such as prior surgery or trauma. However, non-traumatic or surgical immobility has also been demonstrated to be an important risk factor for VTE, even after short periods of time, and particularly for VTE associated with certain diseases.
Villalba
Juan Carlos
JC
Departamento de Medicina Interna, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España.
Monreal
Manuel
M
D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D017985:Dalteparin / Q000008:administration & dosage / Q000627:therapeutic use; D017984:Enoxaparin / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000077425:Fondaparinux; D006699:Home Care Services; D006760:Hospitalization; D006801:Humans; D007103:Immobilization / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011134:Polysaccharides / Q000008:administration & dosage / Q000627:therapeutic use; D015995:Prevalence; D011655:Pulmonary Embolism / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013997:Time Factors; D054556:Venous Thromboembolism / Q000453:epidemiology* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000453:epidemiology
D000925:Anticoagulants; D017984:Enoxaparin; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux; D017985:Dalteparin